NewsMCA Approves Fast-Track Amalgamation of Two Entero Healthcare Subsidiaries with Rada MedisolutionsMCA Approves Fast-Track Amalgamation of Two Entero Healthcare Subsidiaries with Rada Medisolutions
Entero Healthcare Solutions Limited disclosed that the MCA's Regional Director, Southern Region, Chennai, confirmed the fast-track amalgamation of Chethana Pharma Distributors Private Limited and CPD Pharma Private Limited with Rada Medisolutions Private Limited vide confirmation order dated April 17, 2026. The scheme is effective from the Appointed Date of April 15, 2025. Post-amalgamation, the authorised share capital of Rada Medisolutions Private Limited will stand enhanced to INR 1,35,00,000/-, divided into 13,50,000 equity shares of INR 10/- each. No new shares will be issued as consideration since both transferor companies were wholly owned subsidiaries of the transferee company.
*this image is generated using AI for illustrative purposes only.
Entero Healthcare Solutions Limited has informed the stock exchanges that the Ministry of Corporate Affairs (MCA), through the Office of the Regional Director, Southern Region, Chennai, has approved the Scheme of Amalgamation involving two of its group subsidiaries. The confirmation order, dated April 17, 2026, was received by the company on May 05, 2026, and the disclosure was made under Regulation 30 and Regulation 37 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, on May 06, 2026.
Scheme Overview
The approved scheme involves the amalgamation of Chethana Pharma Distributors Private Limited (Transferor Company-1) and CPD Pharma Private Limited (Transferor Company-2) with Rada Medisolutions Private Limited (Transferee Company) via the fast-track route under Section 233 of the Companies Act, 2013. The scheme was presented and approved by the respective members and creditors of all three companies as required under Section 233(1)(b) and (d) of the Companies Act, 2013.
Key details of the amalgamation are summarised below:
| Parameter: | Details |
|---|---|
| Transferor Company-1: | Chethana Pharma Distributors Private Limited (CIN: U51909KA2020PTC133694) |
| Transferor Company-2: | CPD Pharma Private Limited (CIN: U51909TN2019PTC130073) |
| Transferee Company: | Rada Medisolutions Private Limited (CIN: U51397TN2019PTC128334) |
| Approval Route: | Fast-track under Section 233, Companies Act, 2013 |
| Confirmation Order Date: | April 17, 2026 |
| Order Received by Company: | May 05, 2026 |
| Appointed Date (Effective From): | April 15, 2025 |
| Approving Authority: | Regional Director, Southern Region, MCA, Chennai |
Share Capital of the Entities
All three entities are engaged in the distribution and marketing of pharmaceutical products, surgical products, and other allied services. As on the Appointed Date (April 15, 2025), both transferor companies were wholly owned subsidiaries of the Transferee Company. The share capital details of each entity, as on the date of Board approval of the scheme, are as follows:
| Entity: | Authorised Capital (INR) | Issued, Subscribed & Paid-up Capital (INR) |
|---|---|---|
| Chethana Pharma Distributors Pvt. Ltd. (Transferor Company-1): | 30,00,000 (3,00,000 equity shares of Rs. 10/- each) | 30,00,000 (3,00,000 equity shares of Rs. 10/- each) |
| CPD Pharma Private Limited (Transferor Company-2): | 25,00,000 (2,50,000 equity shares of Rs. 10/- each) | 25,00,000 (2,50,000 equity shares of Rs. 10/- each) |
| Rada Medisolutions Private Limited (Transferee Company): | 80,00,000 (8,00,000 equity shares of Rs. 10/- each) | 80,00,000 (8,00,000 equity shares of Rs. 10/- each) |
Post-Amalgamation Capital Structure
Upon the scheme becoming effective, the authorized share capital of the Transferee Company will stand enhanced to INR 1,35,00,000/- (Indian Rupees One Crore Thirty Five Lakhs only), divided into 13,50,000 (Thirteen Lakhs Fifty Thousand) equity shares of INR 10/- each. Since both transferor companies were wholly owned subsidiaries of the Transferee Company, no new shares will be issued as consideration, and the share capital of the transferor companies shall stand cancelled upon the scheme becoming effective.
Rationale and Key Provisions
The Board of Directors of the transferor and transferee companies cited the following key rationale for the amalgamation:
- Increased operational efficiencies, economies of scale, and reduction in overheads and compliance costs
- Simplification of group structure by eliminating entities with similar objectives and businesses, thereby reducing corporate redundancies and duplication of administrative and regulatory compliance work
- Better supervision of group business, reduction of managerial overlaps, and prevention of cost duplications
Under the scheme, all assets, liabilities, employees, contracts, legal proceedings, and tax-related matters of the transferor companies will be transferred to and vested in Rada Medisolutions Private Limited with effect from the Appointed Date. The transferor companies shall stand dissolved without being wound up upon the scheme becoming effective, as provided under Section 233(8) of the Companies Act, 2013. Accounting treatment will be carried out in accordance with Indian Accounting Standards (Ind AS) 103 — Business Combinations.
Historical Stock Returns for Entero Healthcare Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.25% | +0.67% | +5.48% | +12.42% | -8.06% | +6.53% |
How will the consolidation of Chethana Pharma and CPD Pharma into Rada Medisolutions impact Entero Healthcare's overall revenue contribution from its Southern Region operations?
Could this subsidiary streamlining signal a broader restructuring strategy by Entero Healthcare to consolidate its remaining group entities, and which subsidiaries might be next?
How might the elimination of duplicate compliance and administrative costs from this amalgamation translate into measurable margin improvements for Entero Healthcare at the consolidated level?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
